171 related articles for article (PubMed ID: 3313993)
1. Sequential conventional and cyclosporine therapy in cadaver renal transplantation--a prospective randomized trial.
Grundmann R; Wienand P; Hesse U
Transplant Proc; 1987 Oct; 19(5):4033-4. PubMed ID: 3313993
[No Abstract] [Full Text] [Related]
2. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
3. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
Belitsky P; MacDonald AS; Cohen AD; Crocker J; Hirsch D; Jindal K; Lawen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
[No Abstract] [Full Text] [Related]
4. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
[No Abstract] [Full Text] [Related]
5. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
6. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
[No Abstract] [Full Text] [Related]
7. Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.
Sollinger HW; Deierhoi M; Kalayoglu M; Belzer FO
Transplant Proc; 1986 Apr; 18(2 Suppl 1):16-8. PubMed ID: 3515685
[No Abstract] [Full Text] [Related]
8. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
9. Triple therapy including cyclosporine A versus conventional regimen--a randomized prospective study in pediatric kidney transplantation.
Broyer M; Gagnadoux MF; Guest G; Niaudet P
Transplant Proc; 1987 Oct; 19(5):3582-5. PubMed ID: 3313862
[No Abstract] [Full Text] [Related]
10. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
[No Abstract] [Full Text] [Related]
11. Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial.
Spielberger M; Aigner F; Schmid T; Bösmüller C; Königsrainer A; Margreiter R
Transplant Proc; 1988 Jun; 20(3 Suppl 3):169-70. PubMed ID: 3291236
[No Abstract] [Full Text] [Related]
12. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine.
Maiorca R; Cristinelli L; Brunori G; Setti G; Salerni B; De Nobili U; Mittempergher F
Transplant Proc; 1988 Jun; 20(3 Suppl 3):121-5. PubMed ID: 3291224
[No Abstract] [Full Text] [Related]
13. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
14. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
Büsing M; Hölzer H; Schareck WD; Mellert J; Greger B; Hopt UT; Lauchart W
Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
[No Abstract] [Full Text] [Related]
15. Improved results using pediatric cadaver donor kidneys with cyclosporine immunosuppression.
Hayes JM; Novick AC; Steinmuller DR; Streem SB; Hodge EE; Bretan PN; Cunningham R; Graneto D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):209-14. PubMed ID: 3291245
[No Abstract] [Full Text] [Related]
16. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
17. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
18. Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.
Hiesse C; Fries D; Charpentier B; Neyrat N; Rieu P; Cantarovich M; Lantz O; Bellamy J; Benoit G
Transplant Proc; 1987 Oct; 19(5):3670-1. PubMed ID: 3313885
[No Abstract] [Full Text] [Related]
19. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
[No Abstract] [Full Text] [Related]
20. Australian multicentre trial in cadaver renal transplantation comparison of short- and long-term cyclosporine A therapy with conventional therapy.
Hall BM; Sheil AG; Tiller DJ; Hardie I; Mahoney J; Thatcher G; Mathew T; Thompson N; Miach P
Transplant Proc; 1987 Feb; 19(1 Pt 3):1833-4. PubMed ID: 3079045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
